HCV-Infected Hearts, Lungs Safe With Preemptive Antivirals HCV-Infected Hearts, Lungs Safe With Preemptive Antivirals
Excellent survival and graft function was seen in uninfected organ recipients after a short course of antiviral treatment in a pilot trial. The findings could potentially expand the organ donor pool.Medscape Medical News
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Cardiology News Source Type: news
More News: Cardiology | Heart | Heart Transplant | Lung Transplant | Transplant Surgery | Transplants